Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis [28]

Lancet

Volumn 348, Issue 9029, 1996, Pages 764-

  Greinacher, A ^a   Zinn, S ^a   Wizemann, ^a   Birk, U W ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTICOAGULANT AGENT; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; THROMBOCYTE FACTOR 4;

ANTIBODY DETECTION; BLEEDING; CELL SURFACE; ENDOTHELIUM CELL; HEMODIALYSIS; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

EID: 0029762726     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65684-X     Document Type: Letter

References (5)

1. GP Vistenin RH Aster Heparin-induced thrombocytopenia and thrombosis Hematology 2 1995 351 357
2. TE Warkentin MN Levine J Hirsh Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
3. A Greinacher J Amiral V Dummel AM Vissac V Kiefel C Mueller-Eckhardt Laboratory diagnosis of heparin-associated thrombocytopenia, comparison of platelet activation (HIPA) test, and PF4/heparin ELISA Transfusion 30 1994 381 385
4. JK Burgess R Lindemann C Chesterman BH Chong Single amino acid mutation of Fc7 receptor is associated with the development of heparin-induced thrombocytopenia Br J Haematol 91 1995 761 766
5. B Potzsch C Unkrig K Madlener A Greinacher G Müller-Berghaus APC resistance and early onset of oral anticoagulation are high thrombo-cytopenia risk factors in patients with heparin-associated thrombocytopenia (HAT) Ann Hematol 72 1 1996 26